Skip to content

A Randomized, Equivalence Trial of Percutaneous Lumbar Adhesiolysis and Caudal Epidural Steroid Injections

Comparative Effectiveness of Percutaneous Adhesiolysis and Caudal Epidural Steroid Injections in Low Back and/or Lower Extremity Pain: A Randomized, Equivalence Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01053273
Enrollment
120
Registered
2010-01-21
Start date
2010-02-28
Completion date
2014-01-27
Last updated
2017-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Keywords

Low back pain, Post lumbar laminectomy syndrome, Lumbar spinal stenosis, Local anesthetic steroid, Lumbar transforaminal epidural injection, Percutaneous epidural adhesiolysis, Caudal epidural injection

Brief summary

The purpose of this study is to: * evaluate the effectiveness of percutaneous epidural adhesiolysis in managing chronic low back and/or lower extremity pain in patients without post lumbar surgery syndrome or spinal stenosis and compare with fluoroscopically directed caudal epidural steroid injections. * evaluate and compare the adverse event profile in all groups.

Detailed description

Recruitment is indicated in patients with chronic low back pain and/or lower extremity pain without post lumbar laminectomy syndrome or spinal stenosis, non-responsive to conservative therapy with physical therapy, chiropractic, medical therapy, and fluoroscopically directed epidural injections. This is a single-center study performed in an interventional pain management referral center in the United States. The study involves 120 patients assigned to one of 2 groups with 60 patients in each group. Data management analysis includes sample size justification of 40 patients in each group with a power of 80% and a 0.05% 2-sided significance level. Statistical methodology includes chi-squared statistics, Fisher's exact test, t-test, and paired t-test with significance evaluated at P value \< 0.05.

Interventions

Group I will receive caudal epidural injections with catheterization up to S3 with local anesthetic, steroids, and 0.9% sodium chloride solution

Group II will receive percutaneous adhesiolysis with targeted delivery of lidocaine, 10% hypertonic sodium chloride solution, and non-particulate betamethasone.

Sponsors

Pain Management Center of Paducah
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with history of lumbar surgery of at least 6 months duration in the past * Patients over the 18 years of age * Patients with a history of chronic function-limiting low back pain with or without lower extremity pain of at least 6 months duration * Patients who are competent to understand the study protocol and provide voluntary, written informed consent and participate in outcome measurements

Exclusion criteria

* Post surgery, central spinal stenosis, and facet joints as sole pain generators * Unstable or heavy opioid use * Uncontrolled psychiatric disorders * Uncontrolled medical illness * Any conditions that could interfere with the interpretation of the outcome assessments * Pregnant or lactating women * Patients with a history or potential for adverse reaction(s) to local anesthetics or steroid.

Design outcomes

Primary

MeasureTime frameDescription
Numeric rating scale (NRS), Oswestry Disability Index (ODI)Outcomes are measured at baseline and at 3, 6, 12, 18, and 24 months post-treatment.duration of significant pain relief, opioid intake, and return to work

Secondary

MeasureTime frameDescription
Adverse event profile of side effects and complications.Adverse events are measured at baseline and at 3, 6, 12, 18, and 24 months post-treatment, and at any time during the procedure or after the procedure the adverse events are suspected or expected.List and look at all side effects and complications

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026